首页> 外文期刊>Progress in Artificial Intelligence >Personalizing age-specific survival prediction and risk stratification in intracranial grade II/III ependymoma
【24h】

Personalizing age-specific survival prediction and risk stratification in intracranial grade II/III ependymoma

机译:个性化年龄特异性的存活预测和颅内级III / III突瘤的风险分层

获取原文
获取原文并翻译 | 示例
           

摘要

Background Models for estimation of survival rates of patients with intracranial grade II/III ependymoma (EPN) are scarce. Considering the heterogeneity in prognostic factors between pediatric and adult patients, we aimed to develop age-specific nomograms for predicting 3-, 5-, and 8-year survival for these patients. Methods A total of 1390 cases (667 children; 723 adults) of intracranial grade II/III EPNs diagnosed between 1988 and 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database for our study. Univariable and multivariable Cox analyses were employed to identify independent prognostic predictors. Age-specific nomograms were developed based on the results of multivariate Cox analyses. We also evaluated the performance of these predictive models by concordance index, calibration curves, time-dependent receiver operating characteristic curves, and decision curve analyses. Results Considerable heterogeneity in prognostic factors was highlighted between pediatric and adult patients. Age, sex, tumor grade, surgery treatment and radiotherapy were identified as significant predictors of overall survival for children, and age, tumor grade, tumor size, surgery treatment, and marital status for adult. Based on these factors, age-specific nomogram models were established and internally validated. These models exhibited favorable discrimination and calibration characteristics. Nomogram-based risk classification systems were also constructed to facilitate risk stratification in EPNs for optimization of clinical management. Conclusions We developed the first nomograms and corresponding risk classification systems for predicting survival in patients with intracranial grade II/III EPN. These easily used tools can assist oncologists in making accurate survival evaluation.
机译:用于估计颅内级II / III介绍(EPN)患者存活率的模型是稀缺的。考虑到儿科和成年患者的预后因素的异质性,我们旨在开发特定年龄的载体,用于预测这些患者的3%,5-岁生存率。方法从1988年至2015年间诊断出诊断的1390例(667名儿童; 723名成人),从监测,流行病学和最终结果(SEER)数据库中提取到1988年至2015年间。使用不可变量和多变量的COX分析来鉴定独立的预测预测因子。基于多元COX分析的结果开发了特定年龄的载体。我们还通过一致性索引,校准曲线,时间相关的接收器操作特性曲线和决策曲线分析来评估这些预测模型的性能。结果儿科和成年患者之间突出了预后因素的相当大的异质性。年龄,性别,肿瘤等级,手术治疗和放疗被确定为儿童整体存活的重要预测因子,年龄,肿瘤等级,肿瘤大小,手术治疗和成人婚姻状况。基于这些因素,建立了年龄特定的拓图模型,内部验证。这些模型表现出良好的歧视和校准特性。还构建了基于载体的风险分类系统,以促进EPN的风险分层以优化临床管理。结论我们开发了第一种载体和相应的风险分类系统,用于预测颅内级III / III EPN患者的存活。这些易用的工具可以帮助肿瘤学家进行准确的生存评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号